John Parker Jr. Overview

  • Primary Position
  • Founder & Managi...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 4

  • Med. Deal Size

John Parker Jr. General Information

Biography

Mr. John Parker is the Founder & serves as Managing Director at CH Innovations. He serves as Vice President of the Board of Trustees and Clerk at the Charles H. Hood Foundation. He is the Founder of Springhood. He serves as a Board Observer at Prapela, BioROSA Technologies, and Argus Cognitive. He has brought 25 years in the alternative investment industry together with over a decade of philanthropic experience to create a new model using investment dollars to make a difference in the lives of kids. He did his MBA from Dartmouth College in 1994, and BA from the same college in 1989.

Contact Information

Primary Position
Founder & Managing Director, CH Innovations
Education
Dartmouth College, MBA (Master of Business Administration)
Dartmouth College, BA (Bachelor of Arts)
Gender
Male
Phone
+1 (617)
Address
  • 2 Boylston Street, 4th Floor
  • C/O Charles H. Hood Foundation
  • Boston, MA 02116
  • United States
+1 (617)

John Parker Jr. Positions (3)

Firm name Firm type Title Location Industry Since
Charles H. Hood Foundation Investor Vice President of the Board of Trustees and Clerk Boston, MA LP Direct Investments
CH Innovations Investor Founder & Managing Director Boston, MA Not-For-Profit Venture Capital
Springhood Investor Founder Boston, MA Venture Capital

John Parker Jr. Board Seats (4)

Company Industry Ownership Status Financing Status Location Since
Argus Cognitive Enterprise Systems (Healthcare) Privately Held (backing) Venture Capital-Backed Hanover, NH
BioROSA Technologies Diagnostic Equipment Privately Held (backing) Venture Capital-Backed Wayland, MA
CH Innovations Boston, MA
Prapela Therapeutic Devices Privately Held (backing) Venture Capital-Backed Biddeford, ME

John Parker Jr. Lead Partner on Deals (4)

John Parker Jr. has been the lead partner on 4 deals. Their latest deal was with NeoPrediX, a decision/risk analysis company. The deal was made for on 12-Sep-2024.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
NeoPrediX 12-Sep-2024 Early Stage VC (Series A) Announced/In Progress Decision/Risk Analysis Regensburg, Germany
Mesentech 13-Apr-2022 Completed Drug Discovery Vancouver, Canada
Breegi Scientific 20-Aug-2019 Later Stage VC Completed Other Devices and Supplies Boston, MA
Prapela 02-Jul-2018 Seed Round Completed Therapeutic Devices Biddeford, ME

John Parker Jr. Network (32)

Board Members (7)

Name Company Representing Location From
John Konsin Prapela Prapela Biddeford, ME
Ashok Srinivasan Ph.D BioROSA Technologies AIF Wayland, MA
BioROSA Technologies OCA Ventures Wayland, MA
BioROSA Technologies Hibiscus Capital Management Wayland, MA
BioROSA Technologies Zoic Capital Wayland, MA

Portfolio Executives (25)

Name Company Role Deal date Location
Sven Wellmann MD NeoPrediX Chief Medical Officer, Board Member & Supervisory Board Member 12-Sep-2024 Regensburg, Germany
Arne Kirchner NeoPrediX Member of Supervisory Board 12-Sep-2024 Regensburg, Germany
NeoPrediX Co-Founder, Chief Strategy Officer & Board Member 12-Sep-2024 Regensburg, Germany
NeoPrediX Chief Financial Officer 12-Sep-2024 Regensburg, Germany
NeoPrediX Member of Supervisory Board & Chairman (Switzerland) 12-Sep-2024 Regensburg, Germany

John Parker Jr. FAQs

  • Who is John Parker Jr.?

    Mr. John Parker is the Founder & serves as Managing Director at CH Innovations.

  • How much does John Parker Jr. typically invest?

    John Parker Jr.'s median deal size is .

  • What is John Parker Jr.’s main position?

    John Parker Jr.’s primary position is Founder & Managing Director.

  • How many active board seats does John Parker Jr. hold?

    John Parker Jr. holds 4 board seats including Argus Cognitive, BioROSA Technologies, CH Innovations, and Prapela.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »